Pericles Calias
Overview
Pericles Calias received an average of $848K in total compensation, including $222K in salary, at Avalo Therapeutics between 2018 and 2019.
Source: SEC filing on April 28, 2020.
Related executives
We found 16 more executives who work or worked at Avalo Therapeutics.
Garry Neil
Avalo Therapeutics
Chief Executive Officer
Stephen Smolinski
Avalo Therapeutics
Former Chief Commercial Officer
Michael Cola
Avalo Therapeutics
Chief Executive Officer
Christopher Sullivan
Avalo Therapeutics
Chief Financial Officer
Schond Greenway
Avalo Therapeutics
Chief Financial Officer
H Wilkins
Avalo Therapeutics
Chief Medical Officer
Simon Pedder
Avalo Therapeutics
Chairman
Joseph Miller
Avalo Therapeutics